WallStSmart
GALT

Galectin Therapeutics Inc

NASDAQ: GALT · HEALTHCARE · BIOTECHNOLOGY

$2.27
+0.89% today

Updated 2026-04-30

Market cap
$156.01M
P/E ratio
P/S ratio
EPS (TTM)
$-0.48
Dividend yield
52W range
$1 – $7
Volume
0.3M

Galectin Therapeutics Inc (GALT) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-6.76M$-5.48M$-4.67M$-3.89M$-3.10M$-5.68M$-7.50M$-7.48M$-12.43M$-16.98M$-16.41M$-15.89M$-10.18M$-10.85M$-20.60M$-24.31M$-31.06M$-32.97M$-41.77M$-23.88M
Capital expenditures$98000.00$42000.00$2000.00$0.00$0.00$5000.00$5000.00$5000.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Depreciation
Stock-based comp$416000.00$616000.00$697000.00$1.61M$1.94M$3.25M$2792.00$3.79M$4.07M$3.40M$2.48M$1.10M$4.45M$1.68M$1.80M$2.08M$2.87M$2.26M$2.45M$1.66M
Free cash flow$-6.86M$-5.53M$-4.67M$-3.89M$-3.10M$-5.68M$-7.50M$-7.49M$-12.43M$-16.98M$-16.41M$-15.89M$-10.18M$-10.85M$-20.60M$-24.31M$-31.06M$-32.97M$-41.77M$-23.88M
Investing cash flow
Financing cash flow
Dividends paid$209000.00$2.07M$1.54M$0.00$976000.00$943000.00$943000.00$741000.00$1.23M$915000.00$394000.00$137000.00$171000.00$97000.00$120000.00$91000.00$138000.00
Share repurchases
Debt repayment
Net change in cash$1.13M$18.64M$-3.28M$-10.48M$-12.31M$5.20M$39.23M$-20.34M